Poland· PL-100050064
Otinum
A other otologicals product containing cholini salicylas, registered in Poland by Bausch Health Ireland Ltd..
Checked against URPL (Poland) on
Informational only — not a medical device.
The record
At a glance
URPL (Poland)- Active substance
- Cholini salicylas
- Manufacturer
- Bausch Health Ireland Ltd.
- Country
- Poland (PL)
- ATC code
- S02D
- ATC class
- OTHER OTOLOGICALS
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 1
- gtin05909990167814
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Cholini salicylas in 1 other country
What each register calls a product with the same active substance — salts and hydrates count as the same.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/c3c818d9-e258-4262-8d91-57348ac99851 GET /v1/drugs/c3c818d9-e258-4262-8d91-57348ac99851?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Krople do uszu",
"source": "urpl",
"strength": "0,2 g/g",
"packaging": "05909990167814 ¦ OTC ¦ 7515\n1 butelka 10 ml",
"substance": "Cholini salicylas 0.2 g/g",
"common_name": "Cholini salicylas",
"pl_product_id": "100050064",
"pozwolenie_nr": "01678",
"auth_procedure": "NAR",
"authorisation_validity": "Bezterminowe"
}See everything about cholini salicylas.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.